Epilog

Epilog was founded to solve a major human challenge - the way we manage the last chapter of our lives (beginning with a life-threatening medical diagnosis). Its focus is on improving quality of life and at the same time reducing the huge economic burden of bad decision-making at this stage in life, in particular the surge in hospital utilization rates in the last year of life. Backed by the world's leading behavioral and palliative experts, the platform is designed with a deep understanding of behavioral principles and actively helps people manage their medical and important life decisions in real-time. Shifting from disease management to life management.

Epilog has raised $1.3M in total funding across 1 rounds. The company is currently at the Pre-Seed stage.

Epilog was founded in 2022 by Tal Shapsa Heiman (Co-founder & CEO), Or Bar Tal (Co-founder & CTO), Dan Ariely (Chief Behavioral Officer), Ron Sabar (Chief Medical Officer).

Epilog operates in Health Tech & Life Sciences, Digital Healthcare, Patient Engagement, with core technologies in Platforms & Interfaces, Mobile, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers, Insurance Companies, Consumers.

Epilog is based in HaArba'a St 19, Tel Aviv-Yafo, Israel.